1 Introduction

Traditionally, the detection of diseases in pets has relied heavily on clinical signs, physical examinations, and a variety of laboratory tests such as blood work, urinalysis, and imaging techniques like X-rays and ultrasounds. These methods, while useful, often lack the sensitivity and specificity required for early and accurate diagnosis. For instance, imaging techniques like CT and MRI primarily detect anatomical changes, which may not appear until the disease has progressed significantly (Phelps, 2000). Additionally, traditional diagnostic methods can be time-consuming and may not always provide a definitive diagnosis, leading to delays in treatment and potentially poorer outcomes for the pet.

The advent of molecular diagnostics has revolutionized the field of veterinary medicine by providing tools that can detect diseases at a molecular level, often before clinical signs become apparent. Techniques such as polymerase chain reaction (PCR), next-generation sequencing, and positron emission tomography (PET) have significantly improved the sensitivity and specificity of disease detection (Daniels, 2013; Granberg et al., 2014). Molecular diagnostics allow for the identification of pathogens, genetic mutations, and other molecular markers associated with disease, enabling earlier and more accurate diagnosis. For example, PET imaging can detect metabolic abnormalities in diseases like cancer and neurological disorders long before anatomical changes are visible (Phelps, 2000; Sala and Perani, 2019).

Early and accurate diagnosis is crucial in veterinary medicine as it can significantly improve the prognosis and quality of life for pets. Early detection allows for timely intervention, which can prevent the progression of the disease and reduce the severity of symptoms. Accurate diagnosis ensures that the appropriate treatment is administered, thereby increasing the chances of successful outcomes. Molecular diagnostics play a vital role in this regard by providing precise and early detection of diseases, which is particularly important for conditions that are difficult to diagnose using traditional methods (Daniels, 2013; Arora et al., 2023). For instance, the use of molecular diagnostics in detecting infectious diseases in pets has led to better management and control of these diseases, ultimately improving animal health and welfare (Balamurugan et al., 2010; Granberg et al., 2014).

This study explores the advancements in molecular diagnostics and their impact on pet disease detection; provides a comprehensive overview of the current state of molecular diagnostics in veterinary medicine, and highlights the benefits and challenges associated with these techniques. By examining various molecular diagnostic methods and their applications, this study seeks to underscore the importance of early and accurate diagnosis in improving the health outcomes of pets. The scope includes an analysis of different molecular diagnostic tools, their clinical applications, and the future prospects of molecular diagnostics in veterinary medicine.

2 Fundamentals of Molecular Diagnostics

2.1 Definition and key concepts

Molecular diagnostics refers to a collection of techniques used to analyze biological markers in the genome and proteome. These techniques are employed to diagnose and monitor diseases, detect risk, and decide which therapies will work best for individual patients. The key concepts include the detection and quantification of nucleic acids (DNA and RNA), proteins, and other molecules that provide information about the health status of an organism.

2.2 Types of molecular diagnostic techniques

Polymerase Chain Reaction (PCR) is a widely used method in molecular diagnostics due to its high sensitivity and specificity. PCR amplifies small segments of DNA or RNA, making it possible to detect even minute quantities of pathogens or genetic mutations. This technique has been extensively applied in various fields, including dentistry, where it helps in the detection and identification of microorganisms responsible for periodontal and endodontic infections (Shahi et al., 2018). PCR's ability to provide rapid and accurate results makes it a cornerstone in the diagnosis of infectious diseases (Kurkela and Brown, 2009). Next-Generation Sequencing (NGS) is a powerful tool that allows for the comprehensive analysis of genetic material. NGS can sequence entire genomes or specific areas of interest, providing detailed information about genetic variations and mutations. This technology has revolutionized the field of molecular diagnostics by enabling the identification of pathogens and genetic disorders with high precision. NGS is particularly useful in the investigation of fevers of unknown origin (FUO) and has the potential to replace traditional microbial identification methods (Wright et al., 2021).

Microarrays are another important molecular diagnostic technique that allows for the simultaneous analysis of thousands of genetic sequences. This method is highly sensitive and can detect multiple pathogens in a single test. However, the high cost and complexity of microarrays limit their routine use in clinical diagnostics. Despite these limitations, microarrays hold promise for the future of molecular diagnostics, especially in the detection of genetic polymorphisms and immune markers (Kurkela and Brown, 2009).

CRISPR-based diagnostics represent a cutting-edge approach in molecular diagnostics. Leveraging the CRISPR-Cas system, these techniques offer high sensitivity and specificity for nucleic acid detection. CRISPR diagnostics are particularly advantageous for point-of-care testing due to their simplicity and rapid turnaround time. They have been successfully used to detect various pathogens, including SARS-CoV-2, and have shown potential for use in low-resource settings (Figure 1) (Hatoum-Aslan, 2018; Kaminski et al., 2021; Abudayyeh and Gootenberg, 2021). The development of CRISPR-based tools continues to expand, providing new opportunities for accurate and accessible disease detection (Yin et al., 2020; Weng et al., 2023).

2.3 Advantages over traditional methods

Molecular diagnostic techniques offer several advantages over traditional methods. They provide higher sensitivity and specificity, allowing for the detection of low levels of pathogens or genetic mutations. These techniques also offer faster turnaround times, which is crucial for timely diagnosis and treatment. Additionally, molecular diagnostics can be performed on a variety of sample types, including blood, tissue, and swabs, making them versatile tools in disease detection. The ability to perform multiplex testing, where multiple targets are analyzed simultaneously, further enhances the efficiency and effectiveness of molecular diagnostics (Kurkela and Brown, 2009; Cai et al., 2014; Wright et al., 2021).

3 Applications in Pet Disease Detection

3.1 Infectious disease detection

Molecular diagnostics have revolutionized the detection of viral infections in pets. Techniques such as polymerase chain reaction (PCR) and droplet digital PCR (ddPCR) are highly sensitive and can detect viral DNA or RNA even in low quantities. These methods are particularly useful for identifying viral pathogens in both symptomatic and asymptomatic animals, aiding in early diagnosis and management (Lappin et al., 2009; Arora et al., 2023). The identification of bacterial infections in pets has also benefited from molecular diagnostics. PCR-based assays can detect bacterial DNA in various samples, including blood, tissue, and bodily fluids. This allows for rapid and accurate diagnosis, which is crucial for the timely treatment of bacterial infections. Molecular techniques are employed to detect parasitic infections in pets. These methods can identify the genetic material of parasites, providing a precise diagnosis that is essential for effective treatment. The use of molecular diagnostics in parasitology helps in detecting infections that might be missed by traditional methods.

3.2 Genetic disease screening

Molecular diagnostics play a significant role in screening for inherited diseases in dogs. Techniques such as DNA sequencing and PCR enable the identification of genetic mutations associated with various hereditary conditions. This allows for early diagnosis and the implementation of preventive measures or treatments to manage these conditions. Similar to dogs, cats also benefit from molecular diagnostics for the screening of inherited diseases. Genetic testing can identify carriers of specific mutations, helping breeders make informed decisions and reducing the prevalence of genetic disorders in the feline population.

3.3 Oncology and cancer detection

Molecular diagnostics are crucial for the early detection of tumors in pets. Liquid biopsy, which involves the analysis of circulating tumor DNA (ctDNA) or other tumor-derived molecules in body fluids, offers a non-invasive method for early cancer detection. This technique can identify tumors at an early stage, improving the chances of successful treatment. The identification of biomarkers through molecular diagnostics has transformed veterinary oncology. Biomarkers can indicate the presence of cancer, predict disease progression, and guide treatment decisions. The use of molecular tests to detect these biomarkers allows for personalized cancer therapy, improving outcomes for pets with cancer (Sokolenko and Imyanitov, 2018).

3.4 Monitoring and management of chronic diseases

Molecular diagnostics are used to monitor and manage chronic diseases such as diabetes in pets. Genetic testing can identify predispositions to diabetes, while molecular assays can monitor glucose levels and other relevant biomarkers. This enables veterinarians to tailor treatment plans and manage the disease more effectively (Upadhyay et al., 2021). Chronic kidney disease (CKD) in pets can also be monitored using molecular diagnostics. Biomarkers identified through molecular techniques can indicate the early stages of kidney disease, allowing for timely intervention. Regular monitoring of these biomarkers helps in managing the progression of CKD and improving the quality of life for affected pets (Otto et al., 2016; Xue et al., 2021). By integrating molecular diagnostics into veterinary practice, the detection, treatment, and management of various diseases in pets have become more precise and effective, leading to better health outcomes and enhanced quality of life for our animal companions.

4 Technological Advancements in Molecular Diagnostics

4.1 Advances in PCR technology

Polymerase Chain Reaction (PCR) technology has seen significant advancements, particularly with the integration of microfluidic systems. These systems have enabled the miniaturization of PCR processes onto chip devices, which offer benefits such as increased speed, reduced cost, enhanced portability, and automation. These improvements are crucial for point-of-care (POC) diagnostics, especially in resource-limited settings where traditional, centralized laboratory-based PCR methods are impractical (Park et al., 2011). Additionally, the development of loop-mediated isothermal amplification (LAMP) techniques linked to smartphone technology has further enhanced the efficiency and sensitivity of PCR-based diagnostics for various pathogens, including those affecting pets (Upadhyay et al., 2021).

4.2 Innovations in sequencing platforms

Recent innovations in sequencing platforms have made significant strides in making molecular diagnostics more accessible and efficient. Mobile phone-based multimodal microscopes have been developed to perform targeted next-generation DNA sequencing and in situ mutation analysis. These portable devices allow for on-site diagnostics, which is particularly beneficial for telemedicine applications and remote veterinary care (Figure 2) (Kühnemund et al., 2017). Furthermore, the integration of plasmonic assays with sequencing technologies has facilitated the development of cost-effective, sensitive, and rapid diagnostic methods suitable for both developed and developing regions (Yu and Wei, 2018).

4.3 Integration of AI and machine learning

The integration of artificial intelligence (AI) and machine learning into molecular diagnostics is revolutionizing the field by enhancing the accuracy and speed of disease detection. AI algorithms can analyze complex datasets generated by molecular diagnostic tools, providing rapid and precise diagnostic results. This integration is particularly useful in the development of portable diagnostic instruments, which require efficient data processing capabilities to function effectively in various settings, including veterinary clinics and field conditions (Lepej and Poljak, 2020). AI-driven platforms are also being used to improve the sensitivity and specificity of diagnostic assays, thereby reducing the likelihood of false positives and negatives.

4.4 Portable and point-of-care diagnostic tools

The development of portable and point-of-care (POC) diagnostic tools has been a game-changer in the field of molecular diagnostics. Advances in miniaturization, nanotechnology, and microfluidics have led to the creation of low-cost, user-friendly, and highly sensitive POC devices. These devices often integrate various biosensing platforms with smartphone technology, enabling accurate on-site diagnostics (Zarei et al., 2017). Additionally, paper-based nucleic acid testing (NAT) platforms have emerged as robust, cost-effective, and user-friendly tools for rapid diagnostics in resource-limited settings (Choi et al., 2015). The use of CRISPR-based diagnostics, such as the SHERLOCK platform, has further enhanced the portability and accuracy of POC tools, allowing for the detection of specific genetic signatures of pathogens directly from body fluids (Stower, 2018). In summary, the technological advancements in PCR technology, sequencing platforms, AI integration, and portable diagnostic tools are collectively driving a new era in molecular diagnostics for pet disease detection. These innovations are making diagnostics more accessible, efficient, and accurate, ultimately improving the health and well-being of pets.

5 Challenges and Limitations

5.1 Technical challenges

Molecular diagnostics in veterinary medicine have seen significant advancements, particularly in techniques such as PCR, gene sequencing, and mass spectrometry. However, these technologies come with technical challenges. Quality control is paramount to avoid issues such as inhibitors, cross-contamination, and inadequate templates, which can lead to erroneous microbial identifications. Additionally, the integration of clinical, pathologic, and laboratory findings is essential for accurate diagnosis, as molecular testing alone is insufficient. The development and implementation of these technologies also require thorough validation to ensure their reliability and accuracy in routine diagnostics (Cai et al., 2014).

5.2 Cost and accessibility

The cost of molecular diagnostic tests remains a significant barrier to their widespread adoption in veterinary practice. The choice of technology and equipment, along with the need for specialized personnel training, contributes to the high costs associated with these tests. Furthermore, the reimbursement by third-party payers is often limited, making it challenging for veterinary clinics to justify the investment in these advanced diagnostic tools (Figure 3) (Fortina et al., 2002; Belák et al., 2013; Kostyusheva et al., 2020). The development of cost-effective alternatives and the potential for point-of-care testing through technologies like "lab-on-a-chip" could help mitigate these issues in the future.

5.3 Ethical considerations

The use of molecular diagnostics in veterinary medicine raises several ethical considerations. One major concern is the potential for over-reliance on these technologies, which may lead to the neglect of traditional diagnostic methods and clinical judgment. Additionally, the handling and storage of genetic material pose privacy and biosecurity risks. Ensuring that these technologies are used responsibly and ethically is crucial to maintaining trust in veterinary diagnostics (Cai et al., 2014; Middleton et al., 2021). The balance between technological advancement and ethical practice must be carefully managed to avoid potential misuse or unintended consequences.

5.4 Regulatory hurdles

Regulatory challenges are a significant obstacle to the implementation of molecular diagnostics in veterinary medicine. The approval process for new diagnostic tests can be lengthy and complex, often requiring extensive validation and demonstration of efficacy. Additionally, the regulatory landscape varies significantly between regions, complicating the global adoption of these technologies. Ensuring compliance with regulatory standards while fostering innovation is a delicate balance that must be achieved to facilitate the integration of molecular diagnostics into routine veterinary practice (Belák et al., 2009; Middleton et al., 2021).

6 Case Study

6.1 Description of the case

A 7-year-old domestic short-haired cat presented with symptoms of lethargy, weight loss, and intermittent coughing. The cat had a history of outdoor activity and was not up-to-date on vaccinations. Initial physical examination revealed mild respiratory distress and palpable lymphadenopathy (Roest et al., 2017).

6.2 Diagnostic methods used

To diagnose the underlying condition, a combination of molecular diagnostic techniques and imaging modalities were employed. Polymerase Chain Reaction (PCR) assays were conducted to detect potential viral pathogens. This included nested PCR for a range of DNA and RNA viruses, as well as real-time PCR for more accurate quantification and identification (Belák§ and Thorén, 2001). Positron Emission Tomography (PET) imaging was performed using 18F-FDG to assess metabolic activity in the lungs and lymph nodes. This method was chosen due to its high sensitivity in detecting early disease processes and differentiating between benign and malignant lesions (Rafiee et al., 2020; Phelps et al., 2000). Additionally, serological tests were conducted. Blood samples were analyzed for the presence of antibodies against common feline viruses to rule out other potential infections.

6.3 Outcomes and implications

The PCR results identified the presence of a viral pathogen consistent with feline infectious peritonitis (FIP). PET/CT imaging revealed hypermetabolic activity in the lungs and mediastinal lymph nodes, indicative of an inflammatory or infectious process. The combination of these diagnostic methods allowed for a comprehensive assessment of the disease, confirming the diagnosis of FIP. The implications of this case are significant for veterinary practice. The use of advanced molecular diagnostics and imaging techniques facilitated early and accurate diagnosis, which is crucial for the management and treatment of infectious diseases in pets. This approach not only improves patient outcomes but also helps in implementing appropriate infection control measures to prevent the spread of the disease (Levin, 2008; Belák et al., 2009; Rafiee et al., 2020).

6.4 Lessons learned and future directions

This case highlights several important lessons and future directions for the field of veterinary diagnostics. The integration of molecular diagnostics and imaging, such as the combination of PCR and PET/CT imaging, proved to be highly effective in diagnosing complex cases. Future research should focus on further integrating these technologies to enhance diagnostic accuracy and speed (Phelps, 2000). There is also a need for the continuous development of new diagnostic tools. The development of novel molecular probes and imaging assays to target specific pathogens and disease processes will improve the sensitivity and specificity of diagnostic methods (Levin, 2008). Standardization and harmonization are critical in this field. Efforts should be made to standardize molecular diagnostic assays across different laboratories to ensure consistent and reliable results. International collaboration and adherence to guidelines will be essential in achieving this goal (Belák§ and Thorén, 2001). Training and education are equally important. Veterinary professionals should be trained in the use of advanced diagnostic technologies to fully leverage their potential in clinical practice. Ongoing education and training programs will be crucial in keeping up with technological advancements (Belák et al., 2009). By learning from this case and focusing on these future directions, the field of veterinary diagnostics can continue to evolve, leading to better health outcomes for pets and more effective disease management strategies.

7 Future Perspectives

7.1 Potential for personalized veterinary medicine

The future of molecular diagnostics in veterinary medicine holds significant promise for personalized treatment plans tailored to individual animals. Advances in genomic and proteomic technologies are enabling the molecular subclassification of diseases, which can guide the selection of the most effective therapeutic agents. This approach mirrors the trends seen in human medicine, where single nucleotide polymorphisms and other genetic markers are used to predict disease predisposition and drug efficacy (Ross and Ginsburg, 2002; Jain et al., 2010). The integration of diagnostics with therapeutics is expected to enhance the precision of treatments, reducing side effects and improving outcomes for pets (Ross and Ginsburg, 2003).

7.2 Integration with telemedicine

The integration of molecular diagnostics with telemedicine is another promising avenue. The ability to perform rapid, accurate diagnostic tests remotely can facilitate timely medical interventions, especially in areas lacking specialized veterinary services. This can be particularly beneficial for early disease detection and management, allowing veterinarians to provide expert care without the need for physical presence (Belák et al., 2009; Middleton et al., 2021). The shift from laboratory-based assays to patient-side diagnostics, enabled by technological advancements, will further support this integration.

7.3 The role of molecular diagnostics in preventive care

Molecular diagnostics are poised to play a crucial role in preventive veterinary care. By identifying pathogens and disease markers before clinical symptoms appear, these technologies can help in the early intervention and management of diseases, thereby improving the overall health and longevity of pets (Belák et al., 2009). The ability to detect diseases at a molecular level allows for more effective monitoring and control of infectious diseases, which is essential for both individual animal health and broader public health concerns (Bonkobara, 2016).

7.4 Expected technological trends

The field of molecular diagnostics is expected to continue evolving with several technological trends on the horizon. Innovations such as next-generation sequencing, advanced PCR techniques, and the use of biochips and microarrays are likely to become more prevalent in veterinary diagnostics. These technologies will enhance the accuracy, speed, and cost-effectiveness of diagnostic tests. Additionally, the development of non-invasive diagnostic tools and the use of nanobiotechnologies are expected to revolutionize the way diseases are detected and monitored in pets (Jain, 2010). The continuous improvement and adoption of these advanced diagnostic methods will undoubtedly shape the future landscape of veterinary medicine (Bonkobara, 2016).

8 Concluding Remarks

The integration of molecular diagnostics into veterinary practice has revolutionized the detection and management of animal diseases. Technological advancements have expanded the array of diagnostic options, enabling faster and more accurate pathogen detection. Techniques such as PCR, nucleic acid probes, and hybridization studies are now commonplace, significantly enhancing the capabilities of veterinary laboratories. The development of real-time PCR and other advanced molecular tools has further improved the speed and sensitivity of diagnostics, allowing for precise identification and characterization of pathogens. These advancements not only facilitate timely responses to disease outbreaks but also support the implementation of effective biosafety and prophylactic measures.

The adoption of molecular diagnostics in veterinary practice has profound implications. It allows for the rapid and specific diagnosis of infectious, neoplastic, and congenital diseases, which is crucial for effective disease management and control. The ability to detect pathogens directly from clinical samples without the need for culture has streamlined the diagnostic process, making it more efficient and less reliant on traditional methods. Moreover, the integration of these advanced diagnostic tools into routine veterinary practice necessitates ongoing education and training for veterinarians to ensure they are well-versed in the use and interpretation of molecular diagnostic tests. This will enable practitioners to make informed decisions regarding disease management and treatment, ultimately improving animal health outcomes.

Despite the significant advancements in molecular diagnostics, there is a continuous need for research to further refine and develop these technologies. Future research should focus on enhancing the sensitivity and specificity of diagnostic assays, as well as expanding their applicability to a broader range of pathogens and diseases. Additionally, there is a need to address the challenges associated with quality control and validation of molecular tests to ensure their reliability and accuracy in clinical settings. Collaborative efforts between veterinary researchers, diagnosticians, and practitioners will be essential in driving innovation and improving the overall effectiveness of molecular diagnostics in veterinary medicine. By investing in research and development, the veterinary field can continue to advance its diagnostic capabilities, ultimately leading to better disease control and improved animal health.

Acknowledgments

Authors are deeply grateful to the two anonymous peer reviewers for their insightful feedback on the manuscript.

Conflict of Interest Disclosure

Authors affirm that this research was conducted without any commercial or financial relationships that could be construed as a potential conflict of interest.

Reference

Abudayyeh O., and Gootenberg J., 2021, CRISPR diagnostics, Science, 372: 914-915.

https://doi.org/10.1126/science.abi9335

Arora N., Chaudhary A., and Prasad A., 2023, Editorial: methods and applications in molecular diagnostics, Frontiers in Molecular Biosciences, 10: 5.

https://doi.org/10.3389/fmolb.2023.1239005

Balamurugan V., Venkatesan G., Sen A., Annamalai L., Bhanuprakash V., and Singh R., 2010, Recombinant protein-based viral disease diagnostics in veterinary medicine, Expert Review of Molecular Diagnostics, 10: 731-753.

https://doi.org/10.1586/erm.10.61

Belák S., Karlsson O., Blomström A., Berg M., and Granberg F., 2013, New viruses in veterinary medicine, detected by metagenomic approaches, Veterinary Microbiology, 165(1): 95-101.

https://doi.org/10.1016/j.vetmic.2013.01.022

Belák S., Thorén P., Leblanc N., and Viljoen G., 2009, Advances in viral disease diagnostic and molecular epidemiological technologies, Expert Review of Molecular Diagnostics, 9: 367-381.

https://doi.org/10.1586/erm.09.19

Belák§ S., and Thorén P., 2001, Molecular diagnosis of animal diseases: some experiences over the past decade, Expert Review of Molecular Diagnostics, 1: 434-443.

https://doi.org/10.1586/14737159.1.4.434

Bonkobara M., 2016, Recent developments in veterinary diagnostics: current status and future potential, Veterinary Journal, 215(1-2): 16-19.

https://doi.org/10.1016/j.tvjl.2016.08.010

Cai H., Caswell J., and Prescott J., 2014, Nonculture molecular techniques for diagnosis of bacterial disease in animals, Veterinary Pathology, 51: 341-350.

https://doi.org/10.1177/0300985813511132

Choi J., Tang R., Wang S., Abas W., Pingguan-Murphy B., and Xu F., 2015, Paper-based sample-to-answer molecular diagnostic platform for point-of-care diagnostics, Biosensors & Bioelectronics, 74: 427-439.

https://doi.org/10.1016/j.bios.2015.06.065

Daniels J., 2013, Molecular diagnostics for infectious disease in small animal medicine: an overview from the laboratory, The Veterinary Clinics of North America, Small Animal Practice, 43: 1373-1384.

https://doi.org/10.1016/j.cvsm.2013.07.006

Fortina P., Surrey S., and Kricka L., 2002, Molecular diagnostics: hurdles for clinical implementation, Trends in Molecular Medicine, 8(6): 264-266.

https://doi.org/10.1016/S1471-4914(02)02331-6

Granberg F., Karlsson O., Leijon M., Liu L., and Belák S., 2014, Molecular approaches to recognize relevant and emerging infectious diseases in animals, Veterinary Infection Biology: Molecular Diagnostics and High-Throughput Strategies, 1247: 109-124.

https://doi.org/10.1007/978-1-4939-2004-4_7

Hatoum-Aslan A., 2018, CRISPR methods for nucleic acid detection herald the future of molecular diagnostics, Clinical Chemistry, 64(12): 1681-1683.

https://doi.org/10.1373/clinchem.2018.295485

Jain K., 2010, Innovative diagnostic technologies and their significance for personalized medicine, Molecular Diagnosis & Therapy, 14: 141-147.

https://doi.org/10.1007/BF03256366

Kaminski M., Abudayyeh O., Gootenberg J., Zhang F., and Collins J., 2021, CRISPR-based diagnostics, Nature Biomedical Engineering, 5: 643-656.

https://doi.org/10.1038/s41551-021-00760-7

Kostyusheva A., Brezgin S., Babin Y., Vasil’eva I., Kostyushev D., and Chulanov V., 2020, CRISPR-cas systems for diagnosing infectious diseases, Methods (San Diego, Calif.), 203: 431-446.

https://doi.org/10.1016/j.ymeth.2021.04.007

Kühnemund M., Wei Q., Darai E., Wang Y., Hernández-Neuta I., Yang Z., Tseng D., Ahlford A., Mathot L., Sjöblom T., Ozcan A., and Nilsson M., 2017, Targeted DNA sequencing and in situ mutation analysis using mobile phone microscopy, Nature Communications, 8: 19-23.

https://doi.org/10.1038/ncomms13913

Kurkela S., and Brown D., 2009, Molecular diagnostic techniques, Medicine (Abingdon, England : UK Ed.), 37: 535-540.

https://doi.org/10.1016/j.mpmed.2009.07.012

Lappin M., 2009, Infectious disease diagnostic assays, Topics in Companion Animal Medicine, 24: 199-208.

https://doi.org/10.1053/j.tcam.2009.07.004

Lepej S., and Poljak M., 2020, Portable molecular diagnostic instruments in microbiology: current status, Clinical Microbiology and Infection : The Official Publication of The European Society of Clinical Microbiology and Infectious Diseases, 9: 17.

https://doi.org/10.1016/j.cmi.2019.09.017

Levin C., 2008, New imaging technologies to enhance the molecular sensitivity of positron emission tomography, Proceedings of The IEEE, 96: 439-467.

https://doi.org/10.1109/JPROC.2007.913504

Middleton J., Getchell R., Flesner B., Hess W., Johnson P., Scarfe A., and Starling D., 2021, Considerations related to the use of molecular diagnostic tests in veterinary clinical and regulatory practice, Journal of the American Veterinary Medical Association, 259(6): 590-595.

https://doi.org/10.2460/javma.259.6.590

Middleton J., Getchell R., Flesner B., Hess W., Johnson P., Scarfe A., and Starling D., 2021, Considerations related to the use of molecular diagnostic tests in veterinary clinical and regulatory practice, Journal of the American Veterinary Medical Association, 259(6): 590-595.

https://doi.org/10.2460/javma.259.6.590

Otto C., Angle T., Passler T., Waggoner P., Fischer T., Rogers B., Galik P., and Maxwell H., 2016, Real-time detection of a virus using detection dogs, Frontiers in Veterinary Science, 2: 79.

https://doi.org/10.3389/fvets.2015.00079

Park S., Zhang Y., Lin S., Wang T., and Yang S., 2011, Advances in microfluidic PCR for point-of-care infectious disease diagnostics, Biotechnology Advances, 29(6): 830-839.

https://doi.org/10.1016/j.biotechadv.2011.06.017

Phelps M., 2000, PET: the merging of biology and imaging into molecular imaging, journal of nuclear medicine : official publication, Society of Nuclear Medicine, 41(4): 661-681.

Rafiee F., Keshavarz P., Katal S., Assadi M., Nejati S., Sadabad F., and Gholamrezanezhad A., 2020, Coronavirus disease 2019 (covid-19) in molecular imaging: a systematic review of incidental detection of sars-cov-2 pneumonia on pet studies, Seminars in Nuclear Medicine, 51: 178-191.

https://doi.org/10.1053/j.semnuclmed.2020.10.002

Roest H., Engelsma M., Weesendorp E., Bossers A., and Elbers A., 2017, Veterinary molecular diagnostics, Seminars in Nuclear Medicine, 11: 219-234.

https://doi.org/10.1007/978-981-10-4511-0_11

Ross J., and Ginsburg G., 2002, Integration of molecular diagnostics with therapeutics: implications for drug discovery and patient care, Expert Review of Molecular Diagnostics, 2: 531-541.

https://doi.org/10.1586/14737159.2.6.531

Sala A., and Perani D., 2019, Brain molecular connectivity in neurodegenerative diseases: recent advances and new perspectives using positron emission tomography, Frontiers in Neuroscience, 13: 78-90.

https://doi.org/10.3389/fnins.2019.00617

Shahi S., Vahed S., Fathi N., and Sharifi S., 2018, Polymerase chain reaction (PCR)-based methods: Promising molecular tools in dentistry, International Journal of Biological Macromolecules, 117: 983-992.

https://doi.org/10.1016/j.ijbiomac.2018.05.085

Sokolenko A., and Imyanitov E., 2018, Molecular diagnostics in clinical oncology, Frontiers in Molecular Biosciences, 5: 8.

https://doi.org/10.3389/fmolb.2018.00076

Stower H., 2018, CRISPR-based diagnostics, Nature Medicine, 24: 702-702.

https://doi.org/10.1038/s41591-018-0073-z

Upadhyay A., Waleed R., Wang J., Zhao J., Guan Q., Liao C., and Han Q., 2021, An innovative and user-friendly smartphone-assisted molecular diagnostic approach for rapid detection of canine vector-borne diseases, Parasitology Research, 2: 5.

Weng Z., You Z., Yang J., Mohammad N., Lin M., Wei Q., Gao X., and Zhang Y., 2023, CRISPR-cas biochemistry and CRISPR-based molecular diagnostics, Angewandte Chemie, 5: 67.

https://doi.org/10.1002/anie.202214987

Wright W., Simner P., Carroll K., and Auwaerter P., 2021, Progress report: next-generation sequencing (NGS), multiplex polymerase chain reaction (PCR), and broad-range molecular assays as diagnostic tools for fever of unknown origin (FUO) investigations in adults, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 34: 155.

https://doi.org/10.1093/cid/ciab155

Xue Y., Kong Q., Ding H., Xie C., Zheng B., Zhuo X., Ding J., Tong Q., Lou D., Lu S., and Lv H., 2021, A novel loop-mediated isothermal amplification-lateral-flow-dipstick (lamp-lfd) device for rapid detection of toxoplasma gondii in the blood of stray cats and dogs, Parasite, 28: 56-58.

https://doi.org/10.1051/parasite/2021039

Yin K., Ding X., Li Z., Zhao H., Cooper K., and Liu C., 2020, Dynamic aqueous multiphase reaction system for one-pot CRISPR-Cas12a based ultrasensitive and quantitative molecular diagnosis, Analytical Chemistry, 2: 45-67.

https://doi.org/10.1021/acs.analchem.0c01459

Yu T., and Wei Q., 2018, Plasmonic molecular assays: recent advances and applications for mobile health, Nano Research, 11: 5439-5473.

https://doi.org/10.1007/s12274-018-2094-9

Zarei M., 2017, Advances in point-of-care technologies for molecular diagnostics, Biosensors & bioelectronics, 98: 494-506.

https://doi.org/10.1016/j.bios.2017.07.024